RE: Prem8 Jan 2025 18:39
Nobody has been happy with the GR performance, for sometime. But the testing that's happening now - in Zimbabwe - is critical to the company's future.
It'll be very closely analysed by the market (and keyboard warriors). Expertise has been imported; they may, or not, pay their way.
Canmax are watching too - their 6 Jan GM confirmed their P role. C have an urgent need for spodumene, and obviously see Prem as a potential source.